NCT06203600 2026-03-17
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
National Cancer Institute (NCI)
Phase 2/3 Recruiting
Clinical Trials
51 trialsNCT07221357 2026-03-17
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb
Phase 2/3 Recruiting
NCT07221149 2026-03-04
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Bristol-Myers Squibb
Phase 2/3 Recruiting
NCT05174169 2026-03-03
CIRCULATE-US
NRG Oncology
Phase 2/3 Recruiting
NCT06721520 2026-02-25
EMPTY
The Cleveland Clinic
Phase 2/3 Recruiting
NCT03051464 2026-02-17
Morpheus
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2/3 Recruiting
NCT07044453 2026-02-17
PANACHE 02
University Hospital, Rouen
Phase 2/3 Recruiting
NCT06989437 2026-02-06
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Pfizer
Phase 2/3 Recruiting
NCT04749108 2026-02-05
GRECCAR14
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2/3 Recruiting
NCT06904170 2026-02-03
ALICE
UNICANCER
Phase 2/3 Recruiting
NCT06312982 2026-01-13
A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer
Beijing Friendship Hospital
Phase 2/3 Recruiting
NCT04353375 2025-12-31
HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma
Hutchmed
Phase 2/3 Recruiting
NCT06361888 2025-12-30
A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
Hutchmed
Phase 2/3 Recruiting
NCT07293468 2025-12-19
BIIRTH
Tuen Mun Hospital
Phase 2/3 Recruiting
NCT07272772 2025-12-09
Colon Cancer Diagnosis With FAPI-PET Imaging
Turku University Hospital
Phase 2/3 Recruiting
NCT06783140 2025-12-05
PLATINUM-CAN
University Health Network, Toronto
Phase 2/3 Recruiting
NCT05768178 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT06007846 2025-09-30
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Health Care Services
Phase 2/3 Recruiting
NCT06644937 2025-09-23
Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence
Zhujiang Hospital
Phase 2/3 Recruiting
NCT07165886 2025-09-10
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2/3 Recruiting
NCT06826079 2025-09-09
SNCCTGC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2/3 Recruiting
NCT06109272 2025-08-15
LIVIGNO-2
AbbVie
Phase 2/3 Recruiting
NCT06958419 2025-08-07
Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2/3 Recruiting
NCT07098598 2025-08-01
Pancreatic Cancer Diagnosis With FAPI-PET Imaging
Turku University Hospital
Phase 2/3 Recruiting
NCT06441565 2025-07-30
Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer
Sun Yat-sen University
Phase 2/3 Recruiting
NCT06280495 2025-05-30
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Sun Yat-sen University
Phase 2/3 Recruiting
NCT06028737 2025-05-06
OCTASUR
Ukrainian Society of Clinical Oncology
Phase 2/3 Recruiting
NCT05065957 2025-04-30
Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
InnoPharmax Inc.
Phase 2/3 Recruiting
NCT06214572 2025-04-11
RUGB
Tata Memorial Centre
Phase 2/3 Recruiting
NCT06355427 2025-04-11
FAPIChol
Erasmus Medical Center
Phase 2/3 Recruiting
NCT06907602 2025-04-02
ONTRESCC
Peking Union Medical College Hospital
Phase 2/3 Recruiting
NCT05504265 2025-03-20
Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2/3 Recruiting
NCT06037980 2025-02-17
PURITY
Gruppo Oncologico del Nord-Ovest
Phase 2/3 Recruiting
NCT06782412 2025-02-07
FAPIDO
KU Leuven
Phase 2/3 Recruiting
NCT06758830 2025-01-09
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Phase 2/3 Recruiting
NCT05462613 2024-12-20
REPROGRAM-02
Centre Hospitalier Universitaire de Besancon
Phase 2/3 Recruiting
NCT06598033 2024-11-26
Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer
Fudan University
Phase 2/3 Recruiting
NCT06601283 2024-11-26
Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer
Fudan University
Phase 2/3 Recruiting
NCT05254171 2024-11-06
ASPIRE
Panbela Therapeutics, Inc.
Phase 2/3 Recruiting
NCT06185556 2024-08-23
COLDFIRE-III
Amsterdam UMC, location VUmc
Phase 2/3 Recruiting
NCT05833815 2024-08-13
Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Banaras Hindu University
Phase 2/3 Recruiting
NCT06079346 2024-08-13
STOP-PC
Mateon Therapeutics
Phase 2/3 Recruiting
NCT06138028 2024-07-24
Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer
Qingdao Central Hospital
Phase 2/3 Recruiting
NCT06243393 2024-07-10
TROPHIT1
University Hospital Heidelberg
Phase 2/3 Recruiting
NCT06478108 2024-06-27
Interventional Software for Multi-immunotherapy of Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3 Recruiting
NCT06354530 2024-04-09
A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
Army Medical Center of PLA
Phase 2/3 Recruiting
NCT03721744 2024-04-03
A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer
1Globe Biomedical Co., Ltd.
Phase 2/3 Recruiting
NCT06221748 2024-04-03
DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy
RemeGen Co., Ltd.
Phase 2/3 Recruiting
NCT05427383 2023-12-19
KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy
Shanghai JMT-Bio Inc.
Phase 2/3 Recruiting
NCT05408221 2023-03-10
HCC
Shandong New Time Pharmaceutical Co., LTD
Phase 2/3 Recruiting